Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether antiretroviral regimens with good central nervous system (CNS) penetration control HIV in cerebrospinal fluid (CSF) and improve cognition. DESIGN: Multisite longitudinal observational study. SETTING: Research clinics. STUDY PARTICIPANTS: One hundred and one individuals with advanced HIV beginning or changing a new potent antiretroviral regimen were enrolled in the study. Data for 79 participants were analyzed. Participants underwent structured history and neurological examination, venipuncture, lumbar puncture, and neuropsychological tests at entry, 24, and 52 weeks. INTERVENTION: Antiretroviral regimens were categorized as CNS penetration effectiveness (CPE) rank of at least 2 or less than 2. Generalized estimating equations were used to examine associations over the course of the study. MAIN OUTCOME MEASURES: Concentration of HIV RNA in CSF and blood and neuropsychological test scores (NPZ4 and NPZ8). RESULTS: Odds of suppression of CSF HIV RNA were higher when CPE rank was at least 2 than when it was less than 2. Odds of suppression of plasma HIV RNA were not associated with CPE rank. Among participants with impaired neuropsychological performance at entry, those prescribed regimens with a CPE rank of at least 2 or more antiretrovirals had lower composite NPZ4 scores over the course of the study. CONCLUSION: Antiretroviral regimens with good CNS penetration, as assessed by CPE rank, are more effective in controlling CSF (and presumably CNS) viral replication than regimens with poorer penetration. In this study, antiretrovirals with good CNS penetration were associated with poorer neurocognitive performance. A larger controlled trial is required before any conclusions regarding the influence of specific antiretrovirals on neurocognitive performance should be made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calculating correlation coefficients with repeated observations: Part 2—correlation between subjects
Bland, J. M., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.310.6980.633 · Cited by 1,082
Letendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 825
Self-citationChanges to AIDS dementia complex in the era of highly active antiretroviral therapy
Dore, G. J., Correll, P. K., Li, Y., Kaldor, J. M., Cooper, D. A., & Brew, B. J. (1999) · AIDS · doi:10.1097/00002030-199907090-00015 · Cited by 413
McArthur, J. C., McClernon, D. R., Cronin, M. F., Nance‐Sproson, T. E., Saah, A. J., St Clair, M., & Lanier, E. R. (1997) · Annals of Neurology · doi:10.1002/ana.410420504 · Cited by 399
Self-citationEllis, R. J., Hsia, K., Spector, S. A., Nelson, J. A., Heaton, R. K., Wallace, M. R., Abramson, I., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410420503 · Cited by 321
Self-citationBrew, B. J., Pemberton, L., Cunningham, P., & Law, M. G. (1997) · The Journal of Infectious Diseases · doi:10.1086/514001 · Cited by 242
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders
Letendre, S. L., McCutchan, J. A., Childers, M. E., Woods, S. P., Lazzaretto, D., Heaton, R. K., Grant, I., Ellis, R. J., & the HNRC Group (2004) · Annals of Neurology · doi:10.1002/ana.20198 · Cited by 222
Self-citationEvaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia
Sevigny, J. J., Albert, S. M., McDermott, M. P., McArthur, J. C., Sacktor, N., Conant, K., Schifitto, G., Selnes, O. A., Stern, Y., McClernon, D. R., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145763.68284.15 · Cited by 206
Self-citationSchifitto, G., Navia, B. A., Yiannoutsos, C. T., Marra, C. M., Chang, L., Ernst, T., Jarvik, J. G., Miller, E. N., Singer, E. J., Ellis, R. J., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32813384e8 · Cited by 166
Self-citationEllis, R. J., Moore, D. J., Childers, M. E., Letendre, S., McCutchan, J. A., Wolfson, T., Spector, S. A., Hsia, K., Heaton, R. K., & Grant, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.923 · Cited by 163
Self-citation
Cited by
Groups, F. T. C. A. H., Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., et al. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-010-0006-1 · Cited by 1,533
Self-citationOncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
Simioni, S., Cavassini, M., Annoni, J.-M., Rimbault Abraham, A., Bourquin, I., Schiffer, V., Calmy, A., Chave, J.-P., Giacobini, E., Hirschel, B., et al. (2010) · AIDS · doi:10.1097/qad.0b013e3283354a7b · Cited by 702
HIV-associated neurocognitive disorder
Clifford, D. B., & Ances, B. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70269-x · Cited by 670
Self-citationHuman immunodeficiency virus‐associated neurocognitive disorders: Mind the gap
McArthur, J. C., Steiner, J., Sacktor, N., & Nath, A. (2010) · Annals of Neurology · doi:10.1002/ana.22053 · Cited by 445
Self-citationCanestri, A., Lescure, F., Jaureguiberry, S., Moulignier, A., Amiel, C., Marcelin, A. G., Peytavin, G., Tubiana, R., Pialoux, G., & Katlama, C. (2010) · Clinical Infectious Diseases · doi:10.1086/650538 · Cited by 405
Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications
Hong, S., & Banks, W. A. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.10.008 · Cited by 360
Harezlak, J., Buchthal, S., Taylor, M., Schifitto, G., Zhong, J., Daar, E., Alger, J., Singer, E., Campbell, T., Yiannoutsos, C., et al. (2011) · AIDS · doi:10.1097/qad.0b013e3283427da7 · Cited by 331
Self-citationCurrent understanding of HIV-associated neurocognitive disorders pathogenesis
Gannon, P., Khan, M. Z., & Kolson, D. L. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834695fb · Cited by 271
HIV-1 infection and cognitive impairment in the cART era: a review
Schouten, J., Cinque, P., Gisslen, M., Reiss, P., & Portegies, P. (2011) · AIDS · doi:10.1097/qad.0b013e3283437f9a · Cited by 242
“One contrasting smaller study reports less neurocognitive improvement in patients with high CPE rankings [135].”
Monocyte/macrophages and their role in HIV neuropathogenesis
Burdo, T. H., Lackner, A., & Williams, K. C. (2013) · Immunological Reviews · doi:10.1111/imr.12068 · Cited by 208
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Akay, C., Cooper, M., Odeleye, A., Jensen, B. K., White, M. G., Vassoler, F., Gannon, P. J., Mankowski, J., Dorsey, J. L., Buch, A. M., et al. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-013-0227-1 · Cited by 188
“One recent focus in HIV neurovirology is the development of ARVs with greater CNS penetrance (Letendre et al. 2008; Marra et al. 2009; Tozzi et al. 2009; Edén et al. 2010; Heaton et al. 2010; Garvey et al. 2011; Smurzynski et al. 2011).”
BackgroundSubcortical brain atrophy persists even in HAART-regulated HIV disease
Study, M. A. C., Becker, J. T., Sanders, J., Madsen, S. K., Ragin, A., Kingsley, L., Maruca, V., Cohen, B., Goodkin, K., Martin, E., et al. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9113-8 · Cited by 167
“The use of medications with higher CNS penetrance would have offered greater, but not complete protection, to the CNS (Marra et al. 2003; Marra et al. 2009).”
BackgroundCohen, R. A., Seider, T. R., & Navia, B. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0123-4 · Cited by 149
“In one study, decreased CSF Aβ, but not elevated total tau or pTau, was found in people with HAND [84].”
BackgroundRandomized trial of minocycline in the treatment of HIV-associated cognitive impairment
Nakasujja, N., Miyahara, S., Evans, S., Lee, A., Musisi, S., Katabira, E., Robertson, K., Ronald, A., Clifford, D. B., & Sacktor, N. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b9121 · Cited by 67
Self-citationAstrocyte senescence and metabolic changes in response to HIV antiretroviral therapy drugs
Cohen, J., D’Agostino, L., Wilson, J., Tuzer, F., & Torres, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00281 · Cited by 58
“…have indicated that drugs with greater CNS penetration resulted in impaired neurocognitive performance, even though HIV was suppressed better (Marra et al., 2009), and that in HIV-infected patients who have preserved immune function, neurocognitive deficits improved after interruption of…”
BackgroundResultEfavirenz: what is known about the cellular mechanisms responsible for its adverse effects
Apostolova, N., Blas-Garcia, A., Galindo, M. J., & Esplugues, J. V. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.016 · Cited by 49
Metadata
- Authors
- Marra, C. M., Zhao, Y., Clifford, D. B., Letendre, S., Evans, S., Henry, K., Ellis, R. J., Rodriguez, B., Coombs, R. W., Schifitto, G., McArthur, J. C., & Robertson, K.
- Venue
- AIDS
- Published
- 2009-07-17
- Volume
- 23
- Issue
- 11
- Pages
- 1359-1366
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2093635022
- Cited by
- 347
- References
- 17
- FWCI
- 22.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.